Legend Biotech EPS - Earnings per Share 2019-2021 | LEGN

Legend Biotech annual and quarterly earnings per share history from 2019 to 2021. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Legend Biotech EPS for the quarter ending September 30, 2021 was $-0.86, a 72% increase year-over-year.
  • Legend Biotech EPS for the twelve months ending September 30, 2021 was $-2.49, a 12.01% decline year-over-year.
  • Legend Biotech 2020 annual EPS was $-2.56, a 93.94% increase from 2019.
  • Legend Biotech 2019 annual EPS was $-1.32, a 6500% increase from 2018.
  • Legend Biotech 2018 annual EPS was $-0.02, a INF% decline from .
Legend Biotech Annual EPS
2020 $-2.56
2019 $-1.32
2018 $-0.02
Legend Biotech Quarterly EPS
2021-09-30 $-0.86
2021-06-30 $-0.66
2021-03-31 $-0.60
2020-12-31 $-0.37
2020-09-30 $-0.50
2020-06-30 $-1.25
2020-03-31 $-0.44
2019-12-31 $-0.64
2019-09-30 $-0.28
2019-06-30 $-0.28
2019-03-31 $-0.12
2018-12-31 $0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.212B $0.076B
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's lead product consist LCAR-B38M/JNJ-4528, which are in clinical stage. Legend Biotech Corporation is based in Cayman Islands.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $143.655B 9.08
Bio-Rad Laboratories (BIO.B) United States $18.101B 36.73
QIAGEN (QGEN) Netherlands $11.351B 19.22
Biohaven Pharmaceutical Holding (BHVN) United States $7.535B 0.00
Emergent Biosolutions (EBS) United States $2.453B 8.82
Arcus Biosciences (RCUS) United States $2.353B 0.00
Myovant Sciences (MYOV) United Kingdom $1.344B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.156B 0.00
Zymeworks (ZYME) Canada $0.627B 0.00
Ambrx Biopharma (AMAM) United States $0.207B 0.00
SQZ Biotechnologies (SQZ) United States $0.207B 0.00
Enzo Biochem (ENZ) United States $0.154B 19.81